Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
The independent source for health policy research, polling, and news.
541 - 560 of 994 Results
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Before Medicare for All, there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHNs Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
The tax on generous health plans originally envisioned as a way to help pay for the ACA and change consumers behavior has never been implemented, and Congress is considering repeal.
You asked about drug prices, the Cadillac tax on generous insurance plans and why Americans dont know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHNs Julie Rovner to answer those questions.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHNs Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
A case of questionable logic.
Known as authorized generics, in-house spinoffs of brand-name drugs quietly undermine the competition.
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHNs Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients care.
Candidates used their varying views on how to achieve universal coverage whether through Medicare for All or more incremental steps as a means to differentiate themselves from the field.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The drug industry has the biggest lobbying war chest.
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHNs Julie Rovner to discuss this, plus court actions on health issues.
Eighteen years ago, most first responders were not thinking about their future health when they spent hours searching The Pile for the remains of terror victims. Today, their illnesses are a slow-moving epidemiological nightmare that has been as difficult for scientists to study as it has been easy for politicians to overlook.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors Medicare for All plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHNs Julie Rovner to discuss this, plus Planned Parenthoods very bad week, the U.S. House vote to repeal the health laws Cadillac tax on generous health plans, and the reduction in deaths from opioids.
A House committee approved its version of legislation to solve the problem of surprise medical bills. But the measure includes a key provision thats got less support in the Senate.
Banking on new cost estimates, a bipartisan coalition in Congress is poised to try once again to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
穢 2026 KFF